Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Agricultural Development Bank of China
Company

New Horizon Health completes round-D financing of USD20 mln

April 21, 2020


Abstract : New Horizon Health, a biotechnology company in China, announced on Tuesday that it completed a round-D financing of 20 million U.S. dollars. 

BEIJING, April 21 (Xinhua) -- New Horizon Health, a biotechnology company in China, announced on Tuesday that it completed a round-D financing of 20 million U.S. dollars.

The company stated that it got the investment from investors such as Omniscience Capital, a private investment fund focused on healthcare investment, Exome Asset Management, Qiming Venture Partners, Softbank China Venture Capital (SBCVC), and Duke Management Company.

Up to now, New Horizon Health has gained investments of more than 130 million U.S. dollars. With the injection of the round-D financing, it will further consolidate its position in the domestic early cancer screening field, according to the company.

Jason Li, head of Omniscience, said that China's early cancer screening field is on the eve of the robust development. In particular, the new molecular diagnostic technology based on non-invasive means is a very promising blue ocean market.

New Horizon Health, established in 2013, has medical testing laboratories in Beijing, Hangzhou, and Guangzhou. It has launched home screening products targeting bowel cancer, cervical cancer, gastric cancer, and lung cancer, and serving more than 3 million customers.

Zhu Yeqing, co-founder and CEO of New Horizon Health, said that the company will make its home early cancer screening services penetrate into various scenarios such as medical, health, life, consumption, Internet, etc., through extensive industry cooperation in the next step. (Edited by Hu Pingchao with Xinhua Silk Road, hupingchao@xinhua.org)

Scan the QR code and push it to your mobile phone

Keyword: biotechnology health care

Reading:

China's anti-COVID-19 medical team shares experiences with Malaysian health experts, medical personnel

China's BGI helps Serbia build automated COVID-19 testing lab

COVID-19: MOPH establishes business place hygiene supervision regulations before relaxing control measures

Construction of 1st communication tower of China-Laos railway completed

Chinese, Senegalese FMs talk over phone on COVID-19 fight, China-Africa cooperation

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial

Ask Us A Question belt & road login close

If you have any questions, please enter them in the box below.

Reload

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial